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Objective. To investigate whether differences exist in adverse pregnancy outcomes between morbidly obese (body mass index (BMI, 
kg/m2) 40 - 49.9) and super-obese women (BMI ≥50).
Methods. A prospective cohort study was undertaken at Tygerberg Hospital, a referral centre in the Western Cape Province of South 
Africa, of morbidly obese and super-obese pregnant women recruited from the antenatal clinic. Data were collected from the files 6 
weeks after delivery. Primary outcomes included hypertension, diabetes mellitus and fetal macrosomia. Secondary outcomes included 
baseline characteristics, previous complications, antenatal and peripartum complications, and short-term neonatal outcomes.
Results. Sixty-six morbidly obese and 46 super-obese women were enrolled. Super-obese women experienced significantly higher 
incidences of pre-eclampsia (24% v. 9%; p=0.03) and interuterine growth restriction (13% v. 2%; p=0.02) than morbidly obese women, 
and both groups had a high incidence of gestational diabetes (24% v. 24%; non-significant (NS)). Both super-obese and morbidly obese 
women experienced high rates of caesarean section (54% v. 41%; NS). In super-obese women these procedures lasted longer (50 v. 41 
minutes; p<0.01) and there were more surgical complications (36% v. 7%; p=0.01). Prolonged admission (>3 days) after delivery was also 
more common in super-obese women (65% v. 42%; p=0.03).
Conclusion. Super-obese women encounter more major pregnancy complications (especially hypertensive, pre-eclamptic and surgical) 
than morbidly obese women, emphasising the fact that these women should be managed at institutions with sufficient expertise.
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In 2008, the World Health Organization released a 
media statement that highlighted the ‘double burden’ 
of disease in low- and middle-income countries that 
‘continue to deal with the problems of infectious 
disease and under-nutrition’ while ‘at the same time 
they are experiencing a rapid upsurge in chronic disease risk factors 
such as obesity and overweight, particularly in urban settings’.[1]
Obesity has been directly linked to adverse (and at times severe) 
maternal and perinatal outcomes.[2-5] These outcomes have also been 
illustrated in the South African (SA) population.[6] Furthermore, 
obesity is a growing problem across the world and the lifestyle 
accompanying it is associated with a wide spectrum of medical 
problems such as hypertension, diabetes and cardiovascular 
disease.[7] Obesity does not only result in short- and long-term 
complications for the adult woman, but may also lead to adverse 
outcomes in her offspring.[8] Obesity in SA follows the same trend as 
in the rest of the world, with more than a third of all women being 
reported as obese.[9,10]
Super-obesity (body mass index (BMI, kg/m2) ≥50) poses a 
unique challenge to the obstetrician and places a large burden on 
the healthcare environment. Earlier case reports[11] and recently two 
large observation series[12,13] have described the increasing difficulty 
in managing these pregnant women. In 2009 the Committee on 
Nutritional Status During Pregnancy and Lactation of the Institute 
of Medicine instituted a guideline on recommendations for weight 
gain during pregnancy but only had categories for overweight 
(BMI  25 - 29.9) and obese (BMI ≥30) women.[14] They did not 
categorise morbid obesity (BMI ≥40) or super-obesity (BMI ≥50) 
separately.
A systematic review of 35 studies published between 1990 and 
2007 was conducted on the effect of weight gain in pregnancy. 
Almost all sourced studies were observational in design, with no 
standardisation of definitions, methodology, statistical analysis 
of outcomes and long-term follow-up. The data were therefore 
regarded as insufficient to make clear clinical recommendations, 
although the evidence did show some associations between weight 
gain and pregnancy outcomes.[15]
Currently in the Western Cape Province of SA, the provincial 
protocols use a BMI ≥40 as a marker for referral to a higher level 
of care. However, no clear recommendations exist on weight gain 
during pregnancy and there are no specific guidelines for the 
management of obesity in pregnancy in SA. The question arises 
whether there are distinct differences between the pregnancy 
outcomes of morbidly obese and super-obese women and whether 
these two groups should be managed as separate entities. It may be 
argued that certain precautions such as more frequent follow-up and 
more intense monitoring of these patients might improve outcome, 
or at least prevent complications. The aim of this study was to 
investigate whether distinct differences, such as the prevalence 
of gestational hypertension, pre-eclampsia, gestational diabetes 
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mellitus (GDM) and fetal macrosomia, exist between morbidly 
obese (BMI 40 - 49.9) and super-obese pregnant women (BMI ≥50).
Methods
This prospective cohort study was performed at Tygerberg Hospital, 
a secondary and tertiary referral centre in the Western Cape. 
Tygerberg Hospital serves as the referral centre for all morbidly 
obese pregnant women within the region. The study population 
consisted of women with a BMI ≥40. These women were recruited 
in the high-risk antenatal clinic where written informed consent 
was taken before enrolment. Recruitment was not continuous 
but subject to the availability of the principal investigator. Data 
were then collected from the files by the principal author, 6 
weeks after completion of the pregnancy. The primary outcomes 
were gestational hypertension, pre-eclampsia, GDM and fetal 
macrosomia. Secondary outcomes included baseline characteristics, 
previous pregnancy complications, antenatal complications 
(e.g. preterm labour, preterm prelabour rupture of membranes, 
antepartum haemorrhage, etc.), intrapartum complications, 
caesarean deliveries, duration of labour, intrapartum blood loss, 
birth weights, Apgar scores, postpartum complications and length of 
hospital stay.
The following definitions were used:
• Hypertension. Systolic blood pressure ≥140 mmHg or diastolic 
blood pressure ≥90 mmHg, two consecutive measurements at least 
4 hours apart
• Chronic hypertension. Pre-gestational hypertension or onset 
before 20 weeks’ gestation
• Gestational hypertension. Onset of hypertension after 20 weeks’ 
gestation
• Pre-eclampsia. Onset of hypertension after 20 weeks’ gestation plus 
proteinuria (persistent ≥1+ on dipstick or ≥300 mg/24 h)
• Superimposed pre-eclampsia. Development of pre-eclampsia in a 
patient with known chronic hypertension
• Eclampsia. Generalised convulsions associated with hypertension 
and proteinuria in pregnancy
• Macrosomia. Birth weight ≥4 000 g
• Intrauterine growth restriction (IUGR). Estimated fetal weight 
below the 10th centile for gestational age
• Preterm labour: Onset of labour from 26 weeks 0 days but before 
37 weeks 0 days
• GDM. A fasting glucose level ≥5.6 mmol/L or a 2-hour postprandial 
glucose level ≥7.8 mmol/L, in a previously non-diabetic patient
• Puerperal infection. Infection of the genital tract occurring any 
time from labour to the 42nd day after delivery, with ≥2 of the 
following: pelvic pain, oral temperature 38.5oC, vaginal discharge or 
pus draining, foul-smelling discharge, delayed uterine involution
• Gestational proteinuria. Persistent proteinuria on dipstick ≥1+ 
or a daily urine protein of ≥300 mg in the absence of hypertension 
measured after 20 weeks’ gestation.
Blood pressure measurements were taken in a standardised manner 
with a mercury sphygmomanometer or an automated device using 
an appropriately sized (obese) cuff. The women were at rest, seated 
for 5 minutes or in the left lateral position with the cuff at the level 
of the heart. Diastolic blood pressure was measured at the 5th 
Korotkoff sound, which is the disappearance of the sounds. When 
the patients were admitted to a high-dependency unit, direct arterial 
pressures were measured using an invasive arterial line.
Statistical analyses were carried out comparing the morbidly obese 
and super-obese pregnant women. Statistical analysis was performed 
using Statistica 11 from Statsoft.com. Data are expressed as medians 
(ranges), means (standard deviation, SD) or n (%), as appropriate. 
Categorical data were analysed using the χ2 test. Where an expected 
cell value was less than 5, Fisher’s exact test was used. Continuous 
data were analysed with Student’s t-test for parametric and Mann-
Whitney U-test for non-parametric data. A p-value of <0.05 was 
regarded as significant.
The study was approved and registered by the Human Research 
and Ethics Committee of Stellenbosch University (N11-03-097).
Results  
The study was conducted from 12 September 2011 to 26 February 
2013, during which time a total of 66 morbidly obese and 46 super-
obese women were enrolled. None of the women approached 
declined consent. Table 1 depicts the characteristics of the women 
at study entry. Pre-existing hypertension was more prevalent in the 
super-obese group (34.7%) than the morbidly obese group (21.2%) 
but this difference was not significant (p=0.16).
The overview of antenatal events and complications is reflected 
in Table 2. The incidence of pre-eclampsia was significantly higher 
in the super-obese group than in the morbidly obese group (23.9% 
v. 9.1%; p=0.03). In the super-obese group, 5 (10.8%) had early-
onset pre-eclampsia compared with 2 (3.0%) in the morbidly obese 
group; the same trend was noted for late-onset pre-eclampsia (6 
(13.0%) and 4 (6.0%), respectively). The incidence of gestational 
proteinuria was also higher in the super-obese than the morbidly 
obese group, being 4 (8.6%) and 2 (3.0%), respectively (p=0.22). 
When looking at obstetric complications, more super-obese patients 
had antepartum haemorrhage (3 (6.5%) v. 0), but this failed to reach 
statistical significance (p=0.07) and no other differences were shown 
between the two groups. There were no differences in the incidence 
of medical complications such as cystitis and pyelonephritis between 
the two groups. Suboptimal ultrasound views were noted during 
evaluations in 32 (69.6%) of the super-obese and 47 (71.2%) of the 
morbidly obese participants.
Fig. 1 depicts the indications for antenatal admissions. In the 
super-obese group, there were significantly more admissions for 
uncontrolled blood pressure (p=0.04).
During the antenatal period, 43 (93.4%) super-obese patients and 
29 (43.9%) morbidly obese patients underwent assessment by an 
obstetric anaesthetist. The policy at Tygerberg Hospital is to refer 
all pregnant women with a BMI ≥45 for an obstetric anaesthetic 
evaluation. In the super-obese group, 2 women (4.4%) required a 
cardiology assessment and 2 (4.4%) a pulmonology assessment, 
while in the morbidly obese group these numbers were 2 (3.0%) and 
4 (6.0%), respectively.
The intrapartum outcomes of the participants are depicted in 
Table 3. Indicated inductions were performed in 25 (37.9%) of the 
morbidly obese and 19 (41.3%) of the super-obese group (p=0.84). 
The most frequent indications for induction were hypertensive 
disorders (15 in the morbidly obese group v. 18 in the super-obese 
group; p=0.03) and diabetes (11 v. 6, respectively; p=0.79). As a 
method of induction, artificial rupture of the membranes was 
performed more frequently in the morbidly obese than the super-
obese group (12 (48.0%) v. 2 (10.5%); p<0.01). Misoprostol was used 
more frequently in the super-obese group (12 (63.2%) v. 11 (44.0%); 
p=0.3), as was dinoprostone gel (5 (26.3%) v. 0; p=0.01).
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The surgical complications encountered 
in the morbidly obese group were one 
uterine tear and one operation with severe 
adhesions resulting in 1 000 ml blood loss. 
Surgical complications in the super-obese 
group comprised a uterine tear, a ureteric 
injury, a patient with severe haemorrhage 
due to difficult surgery and dense 
adhesions, a case requiring a B-lynch suture 
for an atonic uterus, and a hysterectomy 
for uncontrolled haemorrhage during 
caesarean section for a twin pregnancy. 
Four caesarean sections in the super-obese 
group lasted ≥90 minutes. The indications 
for the caesarean sections are depicted in 
Fig. 2, but none of these indications differed 
significantly.
Table 4 depicts the postpartum and 
neonatal outcomes. The four cases of 
puerperal sepsis in the super-obese group 
were due to pneumonias (2), cellulitis (1) 
and a surgical wound infection. One patient 
in the morbidly obese group had a caesarean 
wound infection. There was only one 
readmission after discharge in each group, 
the indication being blood pressure control.
Discussion
The chief findings of this study were as 
follows: super-obese pregnant women exper-
ienced significantly higher incidences of 
pre-eclampsia (23.9% v. 9.1%; p=0.03) and 
IUGR (13.0% v. 2.0%; p=0.02), but there 
was no difference in the incidence of GDM. 
Both super-obese and morbidly obese 
women experienced high rates of caesarean 
section (54.3% v. 40.9%; NS). In the former 
group, these procedures lasted significantly 
longer (50 v. 41 minutes; p<0.01) and there 
were more complications (36.0% v. 7.4%; 
p=0.01). Prolonged admission (>3 days) 
after delivery was also more common 
in super-obese women (65.2% v. 42.4%; 
p=0.03).
Gestational hypertension has repeatedly 
been shown to be associated with increased 
body mass.[3,12,13] In a large population-based 
cohort study, Robinson et al.[16] reviewed 
pregnancy outcomes stratified by pre-
pregnancy weight, while comparing normal 
weight with overweight and severe obesity. 
They demonstrated a higher incidence 
of gestational hypertension (odds ratio 
(OR) 3.00; 95% confidence interval (CI) 
2.49 - 3.62) in the severe obesity group. In 
contrast, a previous study performed in SA 
failed to show a difference in the incidence 
of gestational hypertension among groups 
with different BMI categories.[6] The index 
study demonstrated that in addi tion to 
a significantly higher incidence of pre-
eclampsia, super-obese pregnant women 
had higher systolic (p<0.01) and diastolic 
values (p=0.02), leading to more antenatal 
admissions for uncontrolled blood pressure 
(p=0.04). In addition to hypertension 
generally, pre-eclampsia speci fically has 
also been linked to obesity.[17] These 
findings could be explained by the chronic 
inflammation associated with obesity 
(further worsened in super-obesity) through 
the production of adipokines such as leptin 
and adiponectin in adipose tissue that lead 
to inflammation, insulin resistance and 
oxidative stress. These processes ultimately 
have a negative effect on the endo thelium 
and cardiovascular system.[18]
On a practical note, correct technique 
when measuring the blood pressure is 
extremely important, especially in obese 
patients, since ‘cuff hypertension’ is a well-
recognised phenomenon when measure-
ments are taken with an inappropriately 
sized cuff.[19]
Obesity is a well-known and strong 
risk factor for gestational diabetes.[20] 
Schrauwers and Dekker[3] demonstrated 
a higher inci dence of GDM in morbidly 
obese women than in those of normal 
Table 1. Patient characteristics at study entry
BMI 40 - 49.9 BMI ≥50 p-value
Patients 66 46
Age (yr), median (range) 32 (18 - 42) 33 (19 - 45) -
BMI, median (range) 44.0 (40 - 49) 52.8 (50 - 71) <0.01
Height (cm), median (range) 160 (142 - 175) 159 (136 - 172) -
Weight (kg), median (range) 114 (89 - 144) 135 (111 - 193) <0.01
Race, n (%)
White 3 (4.5) 2 (4.4) -
Coloured 47 (71.2) 28 (60.9) -
Black 13 (19.7) 15 (32.6) -
Unknown 3 (4.5) 1 (2.2)
Gestational age at booking (wk), median 
(range) 
13 (4 - 35) 13 (4 - 33) -
Gestational age  at enrolment (wk), 
median (range)
29 (9 - 40) 29 (10 - 40) -
Gravidity, median (range) 3 (1 - 6) 3 (1 - 10) -
Parity, median (range) 1 (0 - 4) 2 (0 - 9) -
Pre-existing morbidity, n (%)
Hypertension 14 (21.2) 16 (34.7) -
Diabetes mellitus 2 (3.0) 0 -
Asthma 8 (12.1) 6 (13.0)) -
HIV 1 (1.5) 4 (8.7) -
Smoking, n (%) 22 (33.3) 8 (17.3) 0.06
Alcohol use, n (%) 10 (15.1) 3 (6.5) -
Previous obstetric history, n (%)
Gestational hypertension 13 (19.6) 10 (21.7) -
Pre-eclampsia 3 (4.5) 4 (8.7) -
Gestational diabetes 1 (1.7) 0 -
 Preterm labour/preterm rupture of 
membranes
5 (7.6) 0 0.056
Booking blood pressure (mmHg), 
median (range)
Systolic  130 (100 - 160) 130 (100 - 160) -
Diastolic 80 (50 - 110) 80 (58 - 110) -
Booking proteinuria, n (%) 5 (7.6) 7 (15.2) -
BMI = body mass index (kg/m2).
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weight (22% v. 1%; OR 16.3; 95% CI 3.6 - 
74.5). Similarly, the index study illustrated 
a higher incidence of GDM in both groups 
(24%), although no significant differences 
were seen between the super-obese and 
morbidly obese groups. In comparison with 
a previous SA study on maternal obesity, 
which demonstrated an incidence of 5.1% 
in morbidly obese women,[6] the incidence 
of GDM in the index study is certainly high. 
This difference might be explained by the 
enrolment criteria.
Obesity has been linked to fetal over-
growth with ensuing maternal compli-
cations such as protracted or arrested 
labour, operative vaginal or caesarean 
deliveries, genital tract injuries and post-
partum haemorrhage, as well as fetal com-
pli cations that include shoulder dystocia, 
birth trauma and asphyxia.[13,21] Symphysis-
fundal (SF) measurement is often used as 
a screening tool to evaluate the growth of 
the fetus, but is understandably inaccurate 
in obese and super-obese women. In the 
index study the great discrepancy between 
SF measurements plotted ≥90th centile, as 
well as the number of macrosomic babies 
born, illustrates this point. Fox et  al.[22] 
highlighted the difficulty of clinical fetal 
weight estimation in women with increased 
BMI (≥30), while Goetzinger et al.[23] also 
demonstrated low detection rates of fetal 
growth abnormalities using clinical esti-
mation across a wide spectrum of BMI 
categories. Although fetal macrosomia and 
obesity is a logical association, IUGR is 
often overlooked in these patients. Maternal 
obesity is a recognised risk for IUGR,[24] 
being associated with increased risks 
of perinatal mortality, birth adaptation 
complications, respiratory distress and 
necrotising enterocolitis.[25] In the index 
study the incidence of IUGR was greater 
(p=0.02) in the super-obese group. This 
is in contrast with a recent meta-analysis 
that indicated a decreased risk of low birth 
weight (relative risk 0.84; 95% CI 0.75 - 
0.95) in overweight and obese women. The 
meta-analysis did show an increased risk 
of extremely low birth weight infants in 
the ‘heavier’ woman (for obese OR 1.43; 
95% CI 1.05 - 1.95, and for ‘very obese’ 
OR 1.98; 95% CI 1.36 - 2.89).[26] Because 
of the unreliability of clinical methods of 
determining fetal growth in these women, it 
is advisable to test placental function using 
umbilical artery Doppler measurements, or 
perform serial fetal biometry if resources 
allow. This emphasises the fact that such 
women should be managed at institutions 
with sufficient expertise.
Recent publications have expressed 
concern regarding the number of medically 
indicated preterm deliveries in women from 
high BMI categories across all gestational 
ages, whereas the risk of spontaneous 
preterm birth was only increased in the 
extremely preterm deliveries.[27] In the index 
study, indicated preterm inductions were 
more frequent in the super-obese group, 
although statistical significance could not 
be reached, possibly because of the numbers 
in this study. Similarly, there were no 
differences in the incidences of spontaneous 
preterm labour or preterm prelabour 
rupture of membranes.
Obesity has been linked to high rates 
of caesarean section as well as intra- and 
postoperative complications.[13,28,29] It was 
even proposed that a ‘dose-response’ 
relationship exists between worsening 
obesity and caesarean delivery in a recent 
large population-based retrospective cohort 
study.[30] In the index study, caesarean 
sections in super-obese women took longer 
to perform (p<0.01) and were associated 
with more complications (p=0.01). At the 
study institution, patients who undergo 
caesarean section are routinely discharged 
on postoperative day 3. For this reason 
the number of discharges after day 3 was 
investigated. Significantly more women 
in the super-obese group had a prolonged 
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Fig. 1. Indications for antenatal admissions. (uHP = uncontrolled hypertensive disorders; 
Medical = medical disorders; sPTL = spontaneous preterm labour; PPROM = preterm pre-
labour rupture of membranes; APH = antepartum haemorrhage; IUGR = intrauterine growth 
restriction.)
Table 2. Antenatal events and complications
BMI 40 - 49.9 BMI ≥50 p-value
Hypertensive complications, n (%) 20 (30.3) 23 (50.0)
Gestational hypertension, n (%) 14 (21.2) 12 (26.0) -
Pre-eclampsia, n (%) 6 (9.1) 11 (23.9) 0.03
 Highest* systolic (mmHg), median 
(range)
140 (100 - 190) 150 (120 - 190) <0.01
 Highest* diastolic (mmHg), median 
(range)
90 (70 - 130) 90 (80 - 120) 0.02
Gestational proteinuria, n (%) 2 (3.0) 4 (8.6)
Gestational diabetes, n (%) 16 (24.2) 11 (23.9) -
Fetal growth
SF ≥90th centile, n (%) 44 (66.7) 28 (60.9) -
SF ≤10th centile, n (%) 1 (1.5) 2 (4.3) -
IUGR, n (%) 1 (1.5) 6 (13.0) 0.02
Macrosomia, n (%) 5 (7.6) 3 (6.5) -
Total antenatal admission days† 3 (1 - 10) 4 (1 - 21) -
BMI = body mass index (kg/m2); SF = symphysis-fundal height; IUGR = intrauterine growth restriction.
*‘Highest’ systolic or diastolic blood pressure refers to highest recorded reading during pregnancy and/or labour.
†Total number of days admitted in hospital during the pregnancy from conception to birth.
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hospital stay (p=0.03). The increased 
burden of intra- and postoperative 
challenges provides another reason for 
managing at least super-obese women at 
institutions providing a higher level of care. 
Although it may be desirable to manage all 
morbidly obese women at such institutions, 
the new pandemic of obesity in many 
countries of the world will overwhelm the 
capacity of most institutions to provide 
such care, hence the importance of BMI 
categorisation (as in this study) that can be 
used to guide health policy.
A paucity of information exists on 
the outcomes of super-obese pregnant 
women. While indications for, and rates 
of, caesarean section, as well as antibiotic 
use, have sometimes been discussed, 
particular surgical details are lacking. 
This study provides additional details 
such as duration, blood loss and specific 
complications of surgery. Limitations of 
this study include its relatively small size, 
as well as the lack of continuous enrolment. 
Only GDM is discussed, as women with 
pre-existing diabetes mellitus were treated 
in a separate specialist clinic. Furthermore, 
the records of nine women (7.4%) could 
not be obtained for inclusion into the study. 
This study should provide the stimulus for 
larger studies to identify risks and effective 
management strategies further in order to 
improve outcomes and inform provincial 
and national policies.
The obesity pandemic continues to 
challenge the health sector, with obstetrics 
being no exception. The findings of this 
study provide evidence to support the 
management of at least super-obese women 
at the level of referral institutions. Such 
facilities are able to perform appropriate 
special investigations and have the 
necessary expertise to provide safe care.
Finally, healthcare practitioners should be 
tireless in advocating a healthy lifestyle.
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Table 4. Postpartum and neonatal outcomes
BMI 40 - 49.9 BMI ≥50 p-value
Hospital stay (days), median (range) 3 (1 - 10) 4 (1 - 21) -
Longer than 3 days, n (%) 28 (42.4) 30 (65.2) 0.03
Complications, n (%) 2 (3.0) 4 (8.7) -
Blood transfusion - 2 (4.3) -
RPOC 1 (1.5) 1 (2.1) -
VTE 1 (1.5) 1 (2.1) -
HDU admission 3 (4.5) 12 (26.0) <0.01
General ICU admission - - -
Postpartum sepsis 1 (1.5) 4 (8.7) 0.07
Wound sepsis 1 (1.5) 1 (2.1) -
Other* - 3 (6.5) -
Neonatal outcomes
Weight (g), median (range) 3 200 (525 - 4 330) 3 430 (640 - 4 690) -
Weight >4 000 g, n (%) 3 (4.5) 5 (10.9) -
Weight <2 500 g, n (%) 7 (10.6) 10 (21.7) -
Weight <1 500 g, n (%) 4 (6.1) 4 (8.7) -
5-min Apgar <7 - - -
Complications - - -
BMI = body mass index (kg/m2); RPOC = retained products of conception; VTE = venous thromboembolism;  
HDU = high-dependency unit; ICU = intensive care unit.
*Pneumonia, cellulitis.
